HBK Sorce Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
5,646
-528
-9% -$23.6K ﹤0.01% 565
2026
Q1
$267K Buy
6,174
+1,486
+32% +$69.3K 0.01% 517
2025
Q4
$224K Sell
4,688
-314
-6% -$15.6K 0.01% 555
2025
Q3
$245K Buy
5,002
+83
+2% +$4.01K 0.01% 522
2025
Q2
$238K Buy
4,919
+120
+3% +$6.13K 0.01% 510
2025
Q1
$266K Buy
4,799
+532
+12% +$28.8K 0.01% 481
2024
Q4
$206K Buy
4,267
+391
+10% +$19.9K 0.01% 535
2024
Q3
$223K Sell
3,876
-420
-10% -$22.7K 0.01% 516
2024
Q2
$208K Buy
+4,296
New +$207K 0.01% 516
2017
Q4
– Sell
-4,071
Closed -$203K – 394
2017
Q3
$203K Buy
+4,071
New +$197K 0.03% 301

Other funds holding SNY

HBK Sorce Advisory's SNY Position: Q2 2026 in Review

HBK Sorce Advisory reduced its Sanofi (SNY) stake by 8.6% in Q2 2026, selling an estimated $23.6K and leaving 5,646 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

HBK Sorce Advisory first reported a position in SNY in Q3 2017 and has held it in 10 quarters since. The position peaked at $267K in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • HBK Sorce Advisory held 5,646 shares of Sanofi worth $242K as of Q2 2026.
  • HBK Sorce Advisory sold 528 Sanofi shares in Q2 2026, an estimated $23.6K.
  • Sanofi made up ﹤0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #565 holding.
  • HBK Sorce Advisory first reported a position in Sanofi in Q3 2017 and has held it in 10 quarters since.
  • HBK Sorce Advisory's Sanofi position peaked at $267K in Q1 2026.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.